MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism in Patients With Prostate Cancer: Orchiectomy vs. Triptorelin
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2015
Price : $35 *
At a glance
- Drugs Triptorelin (Primary)
- Indications Prostate cancer
- Focus Biomarker; Pharmacodynamics
- 27 Oct 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 18 Aug 2015 Planned End Date changed from 1 Jun 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.
- 18 Aug 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.